Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), intramuscular, administered in arm right, administration date 27Jan2021 (Lot number: EL8982) at the age of 59 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Stenosis", start date: 2020 (unspecified if ongoing); "Occluded nerve C6/C7", start date: 2018 (unspecified if ongoing); "Scoliosis", start date: 2016 (unspecified if ongoing); "Migraines", start date: 2011 (unspecified if ongoing); "Neuropathy", start date: 2005 (unspecified if ongoing); "Vitamin D deficiency", start date: 2002 (unspecified if ongoing); "SVT (Supraventricular Tachycardia)", start date: 2000 (unspecified if ongoing); "Arthritis", start date: 1997 (unspecified if ongoing); "Prediabetic", start date: 1996 (unspecified if ongoing); "Hernia (L?)", start date: 1967 (unspecified if ongoing); "Sciatica (primarily left)", start date: 2016 (unspecified if ongoing); "Testosterone deficiency", start date: 2016 (unspecified if ongoing); "Epidural (2)", start date: 2004 (unspecified if ongoing); "Ablation (SVT)", start date: 2001 (unspecified if ongoing); "Asthma", start date: 1996 (unspecified if ongoing); "Prehypertensive", start date: 1996 (unspecified if ongoing); "Allergy/Allergies" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing); "Pain" (unspecified if ongoing); "Tendonitis" (unspecified if ongoing). Family history included: "Diabetic", start date: 2007 (unspecified if ongoing), notes: Mother has diabetes; "Hypertension", start date: 1999 (unspecified if ongoing), notes: Mother, maternal uncle, and maternal grandfather. Concomitant medication(s) included: FLONASE [FLUTICASONE PROPIONATE] taken for hypersensitivity; LISINOPRIL taken for hypertension; MAXALT MLT taken for migraine; TYLENOL ARTHRITIS taken for arthritis; METFORMIN ER taken for diabetes mellitus; VITAMIN B-12 taken for neuropathy peripheral; GLUCOSAMINE & CHONDROITIN & MSM taken for arthritis; FENOFIBRIC ACID [CHOLINE FENOFIBRATE] taken for blood cholesterol abnormal; ATORVASTATIN taken for blood cholesterol abnormal; PROAIR [SALBUTAMOL SULFATE] taken for asthma; GLIMEPIRIDE taken for diabetes mellitus; TIZANIDINE taken for pain; GABAPENTIN; NAPROXEN taken for tendonitis; ACETAMINOPHEN;HYDROCODONE taken for pain. Vaccination history included: Tetanus, administration date: Dec2015, for immunisation. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 27Jan2021, outcome "recovered" (31Jan2021), described as "Injection site pain". Therapeutic measures were not taken as a result of vaccination site pain. Additional information: The patient also takes "D (5K IU) + K (500 mcg) + Centrum (senior Men's)" for vitamin D deficiency. The patient had no prior vaccinations within 4 weeks. Other family history included - Mother: heart disease; Father: prostate cancer; Maternal aunt: breast cancer, liver cancer; Maternal grandfather: systemic cancer; Paternal grandmother: stroke.  No follow-up attempts are possible. No further information is expected.